In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...

A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at ...

In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only ...

A new study from heart researchers at Intermountain Health in Salt Lake City finds that routine coronary artery calcium CT scans are also proving to be effective in uncovering other medical issues in ...

Tomato spotted wilt virus (TSWV) is among the world’s most destructive plant viruses, threatening global tomato yield and quality. Through fine mapping and genetic validation, researchers identified a ...

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester effectively deliver CBD to the brains of mice for neuropathic pain relief with no adverse side effects.

In this randomized clinical trial, a culturally tailored community health worker intervention modestly lowered interdialytic weight gain and improved dialysis adherence and patient activation among ...

People drive significantly less in European cities with a metro system than in cities that only have trams or no rail-based ...

New study from heart researchers at Intermountain Health in Salt Lake City finds that routine coronary artery calcium CT ...

Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with ...

A transitional dialysis program piloted in Austin, TX lowered the use ofcostly emergency dialysis in uninsured people with kidney failure, and it facilitated permanent dialysis access placement and ...

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major ...